We’re developing new mechanism antibiotics to become the new standards of care. We have a clear strategy: through new science and philosophy, we are creating new opportunities to become the standard of care for serious infectious diseases. Our proprietary Discuva Platform is designed to uncover novel bacterial targets and develops new mechanism antibiotics against them. To date, the Discuva Platform has developed two new tar...
We’re developing new mechanism antibiotics to become the new standards of care. We have a clear strategy: through new science and philosophy, we are creating new opportunities to become the standard of care for serious infectious diseases. Our proprietary Discuva Platform is designed to uncover novel bacterial targets and develops new mechanism antibiotics against them. To date, the Discuva Platform has developed two new targets for gonorrhoea, an ESKAPE programme and undisclosed programmes with Roche.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.